In Q3 2013, 162 Israeli high-tech companies raised $660 million, the highest quarterly amount since 2000. Internet companies attracted the largest portion of investments with $179 million, followed by life sciences with $128 million. For the first three quarters of 2013, 474 companies raised $1.63 billion, a 12% increase from the same period in 2012. Venture capital deals accounted for $462 million or 70% of investments in Q3 2013. However, Israeli VC funds only contributed $151 million or 23% of total investments, the lowest share in a decade.
Determinants of Foreign Direct Investment in Nigeriaijtsrd
Extant literature is replete with the benefit of attracting Foreign Direct Investment FDI into an economy, it not only provides developing countries with the much needed capital for investment it also enhances job creation, managerial skills as well as transfer of technology. However, attracting and sustaining FDI inflow in Nigeria have remained a teething problem. This study therefore examined the determinants of foreign direct investment in Nigeria. Specifically the study provides empirical evidence on the influence trade openness, market size, infrastructure, human capital, labour force, natural resources, exchange rate and inflation rate on Foreign Direct Investment FDI in Nigeria using an econometric regression technique of the Ordinary least square OLS . The findings of the study also show that trade openness, market size, infrastructure, exchange rate and inflation rate are statistically significant in explaining the foreign direct investment in Nigeria while human capital, labour force and natural resources are statistically insignificant in explaining the growth of foreign direct investment in Nigeria. The study recommends that The government should make polices that will create a business friendly environment to attract FDI inflows in economy. The government should provide the needed leadership and also ensure political stability in the country. This will attract investors to take the advantage of the market size of the country to FDI into the economy. The government should make policies that will favour trade openness. Trade openness is found to be factor that attracts investors invest in the country. This is lesser barriers to trade encourages investment and the government should provide the needed infrastructure. Necessary infrastructures that will reduce the cost of doing business should be the watch word of every government. Dibua, Emmanuel Chijioke | Edoko, Tonna David | Onwuteaka, Ifeoma Cecilia "Determinants of Foreign Direct Investment in Nigeria" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-5 , August 2019, URL: https://www.ijtsrd.com/papers/ijtsrd25293.pdfPaper URL: https://www.ijtsrd.com/management/public-sector-management/25293/determinants-of-foreign-direct-investment-in-nigeria/dibua-emmanuel-chijioke
Determinants of Foreign Direct Investment in Nigeriaijtsrd
Extant literature is replete with the benefit of attracting Foreign Direct Investment FDI into an economy, it not only provides developing countries with the much needed capital for investment it also enhances job creation, managerial skills as well as transfer of technology. However, attracting and sustaining FDI inflow in Nigeria have remained a teething problem. This study therefore examined the determinants of foreign direct investment in Nigeria. Specifically the study provides empirical evidence on the influence trade openness, market size, infrastructure, human capital, labour force, natural resources, exchange rate and inflation rate on Foreign Direct Investment FDI in Nigeria using an econometric regression technique of the Ordinary least square OLS . The findings of the study also show that trade openness, market size, infrastructure, exchange rate and inflation rate are statistically significant in explaining the foreign direct investment in Nigeria while human capital, labour force and natural resources are statistically insignificant in explaining the growth of foreign direct investment in Nigeria. The study recommends that The government should make polices that will create a business friendly environment to attract FDI inflows in economy. The government should provide the needed leadership and also ensure political stability in the country. This will attract investors to take the advantage of the market size of the country to FDI into the economy. The government should make policies that will favour trade openness. Trade openness is found to be factor that attracts investors invest in the country. This is lesser barriers to trade encourages investment and the government should provide the needed infrastructure. Necessary infrastructures that will reduce the cost of doing business should be the watch word of every government. Dibua, Emmanuel Chijioke | Edoko, Tonna David | Onwuteaka, Ifeoma Cecilia "Determinants of Foreign Direct Investment in Nigeria" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-5 , August 2019, URL: https://www.ijtsrd.com/papers/ijtsrd25293.pdfPaper URL: https://www.ijtsrd.com/management/public-sector-management/25293/determinants-of-foreign-direct-investment-in-nigeria/dibua-emmanuel-chijioke
VC-backed IPOs on the Rise | Aranca Article & PublicationsAranca
Strong equity market performance has encouraged VC-backed companies to return to equity markets through IPOs. Learn more about venture capital backed IPOs, capital market performance of US, China and Europe.
Performing Online Survey’s “An Added Advantage” Over Advertisementijtsrd
In this article we try to study about the importance of performing surveys and they have an added advantage over advertisement. In earlier years manual surveys were done often door to door but off late surveys are being done online all over the world. Most of the nations conduct online surveys and use this as a great strategy to create good products and provide good services to the people and avoid spending heavily on advertisements. Surveys offer many benefits and therefore have become famous for their convenience, comfort and accurate feedback from the consumers. This article is based on the recent trends observed in various sectors where surveys are done and advertisements are offered to the consumer. After doing the marketing research by the companies and the changes in consumer behaviour observed the following conclusion is drawn. Dr. Mamta Bansal | Mr. Mandeep Narang "Performing Online Survey’s “An Added Advantage” Over Advertisement" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-2 , February 2021, URL: https://www.ijtsrd.com/papers/ijtsrd38607.pdf Paper Url: https://www.ijtsrd.com/management/marketing/38607/performing-online-survey’s-“an-added-advantage”-over-advertisement/dr-mamta-bansal
European VC fund Buran Venture Capital and Startups.Watch have conducted the “Investment Catch-up” survey assessing investor attitudes towards the early stage market in Turkey and related factors. This is our first survey aiming to gauge investor sentiment in the Turkish venture capital space.
BGX Investment Report covering venture capital flow into the period of 2018 Q4 and market sentiment for blockchain in 2019. Note: we are not talking about discredited ICOs or cryptocurrency predictions.
There were 87 investment deals with Ukrainian innovative companies in 2016 , which is 32% more than in 2015 - such a data was presented by the Ukrainian Venture Capital and Private Equity Association (UVCA) in its annual market overview. The overview has gathered information on venture, private equity and angel investment deals - their total volume is accounted in 88 mln. USD in 2016. The amount of investments over the past 5 years growth to 400 mln. At the same time, the volume of investment deals decreased on 33% since 2015 (including 13 undisclosed deals), but still is higher than in 2014 at 125%. The reason is few deals in 2015 amounted in dozens of millions.
Distinguishing feature of the market in 2016 is the prevalence of seed-stage deals. Thereby among all deals 73 were made at the seed-stage with the average amount of ticket over 500K USD. So we can expect that these initially invested companies will attract bigger investments in future.
The average ticket amount (on all stages) has grown up to 1M USD in 2016.
Europe & Israel - VC Investment Trends 2015-2018 - Angular VenturesGil Dibner
A data-driven look at venture capital investment trends across Europe and Israel. By Angular Ventures, a specialist seed-stage enterprise tech VC firm investing across the region.
Foreign Portfolio Investment and Human Capital Development in Nigeria 1987 2018ijtsrd
As a result of low savings that characterize their economies, most developing economies scramble for international capital inflows to fill the void in their domestic savings. The international capital can take the form of Foreign Portfolio Investment. There are mixed and conflicting results in past studies on the effect of Foreign Portfolio Investment on Human Capital Development in Nigeria which this study will attempt to resolve. Foreign portfolio investment FPI is an aspect of international capital inflows and involves the transfer of financial assets such as cash, stock or bonds across international borders in want of profit. The main objective of this study is to explore, determine, assess, examine and ascertain the effect of FPI on human capital development in Nigeria. The specific objectives of this study are to explore, determine, assess, examine and ascertain the effects of foreign portfolio investment, market capitalization, exchange rate and interest rate respectively on human capital development in Nigeria. The study adopted ex post facto research design and sourced data sourced data from the Central Bank of Nigeria Statistical Bulletin and Annual Reports and the World Bank Development Indicators which were analyzed using Descriptive Statistics, Augmented Dicker Fuller tests for unit roots and Autoregressive Distributive Lag ARDL for the hypothesis.The study concluded that foreign portfolio investment has both short run and long run positive and significant effects on human capital development. Hence, it is recommended that government should strengthen and deepen the capital market system in Nigeria to sustain existing foreign portfolio investment and attract new ones. Mbanefo Patrick Amaechi "Foreign Portfolio Investment and Human Capital Development in Nigeria: 1987-2018" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-2 , February 2022, URL: https://www.ijtsrd.com/papers/ijtsrd49231.pdf Paper URL: https://www.ijtsrd.com/management/management-development/49231/foreign-portfolio-investment-and-human-capital-development-in-nigeria-19872018/mbanefo-patrick-amaechi
mHealth Israel_IATI_Israeli ICT Industry Review 2015Levi Shapiro
2015 Israeli High-Tech Industry Review. The Review provides a thorough analysis of 2014’s recent developments in Israel's world renowned ICT industry, as well as an outlook for 2015. It analyzes industry dynamics and trends across a range of technology clusters, highlights leading Israeli companies catering to global markets, provides insights into the future of the industry and analyzes recent investments and mergers& acquisitions (M&A) trends affecting the local High-Tech industry.
VC-backed IPOs on the Rise | Aranca Article & PublicationsAranca
Strong equity market performance has encouraged VC-backed companies to return to equity markets through IPOs. Learn more about venture capital backed IPOs, capital market performance of US, China and Europe.
Performing Online Survey’s “An Added Advantage” Over Advertisementijtsrd
In this article we try to study about the importance of performing surveys and they have an added advantage over advertisement. In earlier years manual surveys were done often door to door but off late surveys are being done online all over the world. Most of the nations conduct online surveys and use this as a great strategy to create good products and provide good services to the people and avoid spending heavily on advertisements. Surveys offer many benefits and therefore have become famous for their convenience, comfort and accurate feedback from the consumers. This article is based on the recent trends observed in various sectors where surveys are done and advertisements are offered to the consumer. After doing the marketing research by the companies and the changes in consumer behaviour observed the following conclusion is drawn. Dr. Mamta Bansal | Mr. Mandeep Narang "Performing Online Survey’s “An Added Advantage” Over Advertisement" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-2 , February 2021, URL: https://www.ijtsrd.com/papers/ijtsrd38607.pdf Paper Url: https://www.ijtsrd.com/management/marketing/38607/performing-online-survey’s-“an-added-advantage”-over-advertisement/dr-mamta-bansal
European VC fund Buran Venture Capital and Startups.Watch have conducted the “Investment Catch-up” survey assessing investor attitudes towards the early stage market in Turkey and related factors. This is our first survey aiming to gauge investor sentiment in the Turkish venture capital space.
BGX Investment Report covering venture capital flow into the period of 2018 Q4 and market sentiment for blockchain in 2019. Note: we are not talking about discredited ICOs or cryptocurrency predictions.
There were 87 investment deals with Ukrainian innovative companies in 2016 , which is 32% more than in 2015 - such a data was presented by the Ukrainian Venture Capital and Private Equity Association (UVCA) in its annual market overview. The overview has gathered information on venture, private equity and angel investment deals - their total volume is accounted in 88 mln. USD in 2016. The amount of investments over the past 5 years growth to 400 mln. At the same time, the volume of investment deals decreased on 33% since 2015 (including 13 undisclosed deals), but still is higher than in 2014 at 125%. The reason is few deals in 2015 amounted in dozens of millions.
Distinguishing feature of the market in 2016 is the prevalence of seed-stage deals. Thereby among all deals 73 were made at the seed-stage with the average amount of ticket over 500K USD. So we can expect that these initially invested companies will attract bigger investments in future.
The average ticket amount (on all stages) has grown up to 1M USD in 2016.
Europe & Israel - VC Investment Trends 2015-2018 - Angular VenturesGil Dibner
A data-driven look at venture capital investment trends across Europe and Israel. By Angular Ventures, a specialist seed-stage enterprise tech VC firm investing across the region.
Foreign Portfolio Investment and Human Capital Development in Nigeria 1987 2018ijtsrd
As a result of low savings that characterize their economies, most developing economies scramble for international capital inflows to fill the void in their domestic savings. The international capital can take the form of Foreign Portfolio Investment. There are mixed and conflicting results in past studies on the effect of Foreign Portfolio Investment on Human Capital Development in Nigeria which this study will attempt to resolve. Foreign portfolio investment FPI is an aspect of international capital inflows and involves the transfer of financial assets such as cash, stock or bonds across international borders in want of profit. The main objective of this study is to explore, determine, assess, examine and ascertain the effect of FPI on human capital development in Nigeria. The specific objectives of this study are to explore, determine, assess, examine and ascertain the effects of foreign portfolio investment, market capitalization, exchange rate and interest rate respectively on human capital development in Nigeria. The study adopted ex post facto research design and sourced data sourced data from the Central Bank of Nigeria Statistical Bulletin and Annual Reports and the World Bank Development Indicators which were analyzed using Descriptive Statistics, Augmented Dicker Fuller tests for unit roots and Autoregressive Distributive Lag ARDL for the hypothesis.The study concluded that foreign portfolio investment has both short run and long run positive and significant effects on human capital development. Hence, it is recommended that government should strengthen and deepen the capital market system in Nigeria to sustain existing foreign portfolio investment and attract new ones. Mbanefo Patrick Amaechi "Foreign Portfolio Investment and Human Capital Development in Nigeria: 1987-2018" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-2 , February 2022, URL: https://www.ijtsrd.com/papers/ijtsrd49231.pdf Paper URL: https://www.ijtsrd.com/management/management-development/49231/foreign-portfolio-investment-and-human-capital-development-in-nigeria-19872018/mbanefo-patrick-amaechi
mHealth Israel_IATI_Israeli ICT Industry Review 2015Levi Shapiro
2015 Israeli High-Tech Industry Review. The Review provides a thorough analysis of 2014’s recent developments in Israel's world renowned ICT industry, as well as an outlook for 2015. It analyzes industry dynamics and trends across a range of technology clusters, highlights leading Israeli companies catering to global markets, provides insights into the future of the industry and analyzes recent investments and mergers& acquisitions (M&A) trends affecting the local High-Tech industry.
Turkey Islamic Finance Report 2014: Fundamentals and the Promise of GrowthIslamic_Finance
Thomson Reuters, Islamic Research and Training Institute (IRTI), General Council for Islamic Banks and Financial Institutions (CIBAFI), bring you the Turkey Islamic Finance Report, which provides substantive due diligence on the opportunities for Islamic financial services in the republic.
The report is available for free download on https://www.zawya.com/middle-east/landinglead/turkey/
This document describes the Israel FinTech landscape, approaching the analysis from a FinTech, regulatory, Investment and talent standpoint.
This document serves as a snapshot of the key pillars of a FinTech ecosystem in a country and provides a good overall view of the state of FinTech at a glance.
Israel has a strong culture of innovation bolstered by government support and a highly educated workforce. The country has the largest number of startups per capita in the world, around 1 startup for every 1,400 people. Some of these startups have gone on to be high-profile exits, including Waze, which sold for $1.3 billion, and Mobileye for $15.3 billion. The technology education imparted in army units has helped nurture entrepreneurs in the country.
Key Findings:
- The Israel Defense Forces (IDF) provides potential entrepreneurs with the opportunity to develop a wide array of skills as well as a network.
- The Bank of Israel’s initiatives such as simplifying the process of establishing a new bank, creating an API standard for open banking, and creating the Central Credit Register are aimed to increase competition in the financial services industry.
- As of August 28, 2018, Israel hosts 426 FinTechs, operating in diverse areas including payments, trading and investing, lending and financing, anti-fraud and insurance, with concentration in payment and trading and investing. There is a shift in the start-up business model in the recent years as more and more companies are planning to partner/collaborate with banks.
- Israeli FinTechs are also often born with a global mindset at the start – due to the small domestic market and concentrated nature of the local banking sector. This international-first mindset is often attractive to multinational investors.
- Global and local financial service providers have partnered with startups through incubation and acceleration. Citibank and Barclays set up their innovation centers in 2011. In March 2018, Deutsche Bank also announced plan to establish its technology center.
- In April 2018, insurance company Menorah Mivtachim became a strategic partner with IBM accelerator Alpha Zone, and is selecting advance-stage Israeli insurtech startups for a 20-week acceleration program.
- Israeli tech startups have been attracting investment from local and global investors alike. In the first six months of 2018 more than $400 million was raised in 45 deals, exceeding previous half-year investments by 33% and 45%, respectively. International attention is increasing as international investors participated in 73%of investment deals in the first half of 2018, up from 66% in 2017, and 60% from 2016.
- The Israeli government provides financial support for tech companies through grants offered by the Israel Innovation Authority. In July 2017, the Israeli Ministry of Finance announced a tender for up to four government-backed technology growth funds.
The Ukrainian Venture Capital and Private Equity Association (UVCA) and the audit and consulting company Kreston Ukraine present the “Ukraine venture capital and private equity markets 2020” annual review, which also includes data for 8 months of 2021.
According to the results of 2020, Ukrainian technology companies and their investors closed 188 deals with investors worth USD 533.5 million. About 50% of the deals are small grants (25 and 50 thousand USD) from the Ukrainian Startup Fund. For 2020—2021, it has invested USD 5.3 million in Ukrainian projects.
Just three years ago, Ukraine did not have a single unicorn among its startups. Nowadays, as many as five of them — Gitlab, Grammarly, Bitfury, People.ai, and Ring — raised USD 1.3 bln funding and dominate the global market.
In this review, we analysed the key market trends, such as “investment focus on software projects”, “increase of foreign investors in the Ukrainian market”, “growing quality of Ukrainian startups and their interest in smart money” for the first time. The key drivers and barriers to market development were identified — the respondents noted that despite the imperfect regulatory framework, the country still has enough private capital to promote the sector.
Generally, all market players are unanimous in their outlooks and are quite optimistic about further market development. According to 81% venture and 67% private equity investors surveyed, all quantitative indicators are likely to grow, and high-tech industries traditionally represent the most promising ones.
Ukrainian investors primarily point to the experience and qualification of the team (according to 94% venture and 17% private equity investors surveyed) and the market potential of the business idea (according to 82% venture and 83% private equity investors surveyed), among the key factors for investment decisions. On the other hand, when choosing an investor, startups consider their industry expertise, investment terms, and ‘smart money’ they can get.
The study results show that Ukrainian companies offer attractive, relevant, and globally competitive solutions and demonstrate sustainability and adaptability in COVID-19. Ukraine is gradually transforming from a talent and idea exporter into a big international venture capital market player.
We invest in Ukraine!
Ukrainian IT SECTOR AS OF late 2014
VENTURE ECOSYSTEM AS OF late 2014
VENTURE MARKET: key highlights
$2B+ WORTH STARTUPS
Success stories FROM UKRAINE
10 NEW investors started investing in Ukrainian startups in 2014
New startup funding in the finance sector witnessed a decline in Q1 2019 while early-stage startups form the biggest chunk. Discover the global trends in our latest Insights Report here http://bit.ly/fi_sector
Michigan HealthTech Market Map 2024. Includes 7 categories: Policy Makers, Academic Innovation Centers, Digital Health Providers, Healthcare Providers, Payers / Insurance, Device Companies, Life Science Companies, Innovation Accelerators. Developed by the Michigan-Israel Business Accelerator
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...Levi Shapiro
Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg
Dear Dr. Kornbluth and Mr. Gorenberg,
The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic
harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation.
This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or
unwillingness to rectify this violation through action requires accountability.
Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied
students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots.
The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee.
• The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act.
• The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X.
• The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
mHealth Israel_Healthcare Finance and M&A- What Comes NextLevi Shapiro
Healthcare Finance and M&A, What Comes Next? Presentation by Matthew R. Kittay, National Co-Chair, M&A Practice Group, Fox Rothschild LLP. Includes fundraising and investments. Breakouts by subsector- Healthcare (overall), Healthcare services, Digital health, Biopharma, Pharmatech, Medtech, Healthcare IT. Healthcare transaction distribution breakouts. Exits remain flat. Avoiding common legal pitfalls like IP, compliance, governance structure. Current legislation in health law. IP strategy for healthtech.
Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...Levi Shapiro
Oppenheimer & Co. Inc, co-Head of Healthcare Investment Banking, Michael Margolis, provides H1 Healthcare Financing, Funding and M&A Overview. Table of Contents
1. Broader Market Overview
2. Biotech M&A Market Overview
3. Private Biotech Financing Market Update
4. Key Advice For Healthcare Companies
Current State of Play; Healthcare has Underperformed the Broader Market Over the Last Twelve Months; Signal-to-Noise is Getting Worse; Healthcare IPO Activity has Decreased Significantly Since 20–21 Pandemic Levels; Biotech Financing Activity Has Remained Robust in 2024; Biotech M&A Market Remains Incredibly Active; Biotech M&A Market Remains Incredibly Active; Big Pharma Upcoming Patent Expirations; Since November 2023 Oncology has accounted for over half of all M&A; Oncology, Autoimmune / I&I, and CV & Metabolic Remain the Top Areas in M&A; Small Molecule Beats Out All Other Modalities in M&A Despite IRA Concerns; Value of Big Pharma Acquisitions by Therapeutic Area in Q1 2024; Private Financing Market Update; 2024 Private Placement Activity On Track to Approach, If Not Exceed, 2020 Levels; Oncology, Particularly Solid Tumor, Continues to Attract VC Investors; Despite the IRA, Small Molecules Continue to Attract VC Dollars; Preclinical-Stage Companies Make Up Almost Half of Private Placements in 2023; Valuations by Development Stage – 2023; Typical Biotech Investors Remained Active in Q1 2024; 23 $100M+ Deals were Raised in Q1 2024; Biotech Fundraising Momentum Continued into 2024; Key Advice For Israeli Healthcare Companies; Although Israel has Strong Presence on US Public Markets, There is Room to Grow; Telling Your Story Effectively; Interacting with Investors to Build Long-term Credibility; Seven Simple Rules for Pitch Decks;
Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003Levi Shapiro
Description of the Version Bravo intensive entrepreneurial launch program for 7 Israeli and 7 US former Navy SEALs. Details about each startup concept, the CEOs, the sector, etc.
Radical Life Extension_Dr. Leon Peshkin_Dec 2023Levi Shapiro
Presentation for mHealth Israel by Dr. Leon Peshkin, Harvard Medical School, exploring research into Embryology and Longevity, emphasizing Germline and protein aggregates. Includes current overview, anti aging through history, Lifespan Expansion, ALEC: Animal Life Expectancy in Controls, Scalable Platform in Pharmacobiology, Embryos Cleanse Protein Aggregates, Lysosomal switch triggers proteostasis renewal, Xenopus, Rejuvenation Roadmap, Citizen Science Approach to Aging, Xenopus: Maternal Dowry Molecules, Human Disease Modeling
Israel’s Life Science Hub 2023 English Abstract.pdfLevi Shapiro
The war between Israel and Hamas brings its own set of business
challenges. Challenges that may impact how we communicate with
partners and investors abroad. We should portray the life science sector as resilient and adaptable, even in times of crisis. This document is a a messaging outline for Israel's Life Science Hub despite the war with Hamas. Four key points to emphasize:
1) Global activity (resilience and agility)
2) Continuity of care and preventive medicine
3) World leading clinical trials industry
4) Dynamic scientific, research and entrepreneurial ecosystems
Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...Levi Shapiro
The Future of Digital Health – Nose Dive or Transformation, by Gil Bashe, Dec 4th, 2023 at the mHealth Israel conference. Digital Health Innovation Ecosystem Investment Trends. Data & Methodology. Digital Health Taxonomy. Key Insights for Digital Health Innovation in H1 2023. Global Digital Health Funding Across Regions. Funding in North America. Shifting Focus in North America Digital Health Funding. Investment Focus for Digital Health Venture Funding. Ventures are turning to partnerships for proof points, scale and funding. 2022 new partnerships. North America digital health investor participation. Most active partners in North America. North America Ecosystem Development. Venture distribution by stage. Funding distribution. Comparison to 2022 Funding. Noteworthy deals, noteworthy exits.
Urgent Request and Call for Action for Ensuring Safety and Inclusivity at MITLevi Shapiro
We, 465 MIT Alumni, Staff, and Students, are writing to express our deep concern, fear, and disappointment regarding the recent protest that took place Thursday afternoon, in front of the MIT Stratton Student Center. While we fully support the principles of free
speech and the right to peaceful assembly, it is essential that we also prioritize the safety and well-being of all members of the MIT
community.
During the protest, a particular slogan was prominently displayed and chanted, which has raised significant concerns. The slogan
"From the [Jordan] river to the [Mediterranean] sea, Palestine will be free!" has been a source of contention due to its potential
implications and the real safety risks it poses to Jewish and Israeli students on campus [See video footage attached]. This slogan
has been time and again associated with calls for the destruction of the State of Israel and has been used in contexts that
promote violence, which raises legitimate concerns about the safety and security of our Jewish and Israeli students and staff.
Furthermore, we would like to draw your attention to recent events that demonstrate the potential dangers associated with this
slogan. During the 2023 Israel-Hamas war, British Home Secretary Suella Braverman proposed criminalizing the use of the slogan
in certain contexts, recognizing the potential harm it can cause. Additionally, on October 11, ‘23, Vienna police banned a
demonstration, citing the inclusion of the phrase "from the river to the sea" in invitations, as it was seen as a portrayal of a violation
of Article 2 of the European Convention on Human Rights.
In addition to the use of these derogatory messages, several attendees of the event used hateful wordings and messages towards
Jewish and Israeli bystanders. In one case, a perpetrator aggressively held their bicycles as intended to harm a Jewish MIT student,
stating that “[your] ancestors did not die in the Holocaust so they could kill Palestinians” [See video footage attached]. In another
incident, protesters chanted “one solution, intifada revolution”. In the context of the on-going Israeli-Palestinian conflict, the word
"Intifada" means the armed and violent Palestinian insurrection targeting Israelis, including civilians, which resulted in the killing of
thousands of Israelis in the last few decades.
On Oct. 22nd, a statement by MIT CAA (Coalition Against Apartheid) came to our attention. In this document, MIT CCA states that
they "hold the Israeli regime responsible for all unfolding violence". They later call the October 7th terror attack a "response to
the settler colonial regime", and continue justifying it throughout the document.
In this matter, MIT CAA is justifying the heinous and barbaric crimes committed on Oct 7th. Furthermore, these statements have the
potential to fuel acts of aggression
Overview of the Israeli exhibitors at the 2023 HLTH conference in Las Vegas. Exhibitors included 6Degrees, AppScent, Belong.Life, Datos, Expecting, IntraPosition, Kahun Medical, Kemtai, Maverick, Neteera, QuantaIX, Respiration Scan, Nerivio, Xoltar.
40% of Israeli technology investment is devoted to Life Science. Within that domain, the largest sector is Medical Devices and Digital Health (over 65 percent of companies). In the medical device arena, Israeli scientists and engineers have integrated advanced technologies in electronics, communications and electro-optics to develop world-class innovations in Digital Imaging, Medical Lasers, Telemedicine, Early Diagnostics,
Smart Surgical Equipment and more. Over 600 medical device exporters engaged in a variety of medical application
such as Cardiovascular and Peripheral Vascular, Neurology and Degenerative Diseases, Preparedness and Emergency
Medicine, Intensive Care, Women Health, Orthopedics and Sport Medicine, Gastrointestinal, Infection Control, Ophthalmology, Pain and Wound Management, Oral and Dental Care, Dermatology and Aesthetics
Baptist Health- Engineering the Future of HealthcareLevi Shapiro
Presentation by Mark Coticchia, Chief Innovation Officer, Baptist Health, for mHealth Israel community, September, 2023. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences.
A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies.Innovation is paramount to health system’s performance and reputation.
Becker’s 2019 Advisory Board survey revealed innovation and technology ranked as the top priority among healthcare finance professionals - up from eighth in 2018. 90% healthcare/life science leaders agree that the pandemic will fundamentally change the way they do business, requiring new products, services, processes, and business models (McKinsey: Innovation Through Crisis Survey). Innovation has been proven to help health systems in many ways. A capability and culture of innovation accomplish numerous goals:
Innovation capability and culture improve the care and work environment. They enhance the reputation through recognition for discoveries made at and through Baptist Health. They aid in the recruitment and retention of top talent. And they help systems harness money that otherwise would be leaving the system – licensing revenues and investment returns and corporate research support and donor revenues. Successful Programs - Common Underpinnings. Innovation as a strategic, institutional priority
Program built on institutional assets and centers of excellence
Experienced, professional team
Technology development and sourcing, Dedicated, long term support. Doing healthcare innovation well at a large enterprise takes a highly specialized team and skill set. Collectively, they need to have deep knowledge of healthcare regulation, medical procedures, patient safety, business development, transactions, business law, innovation markets, entrepreneurship, venture capital, commercialization, tech transfer, organizational change management, and much more. Programs- services, technology management, corporate co-creation, global medical service lines and facilities; Focus on market opportunity vs. technology; Select & concentrate on winners; Operate as a business; Proactive in new company formation; Progress, milestones, preliminary results; Building New Innovation Pathways; Improving Treatment for Cancer Patients; Predicting & Preventing Heart Attacks; Improving Outcomes in Cardiac Care; Enhancing a Culture of Innovation at Baptist Health & South Florida; Cleerly, TriVentures, COTA; Innovation is paramount to health system’s performance and reputation.
Baptist Health has established an innovation function predicated on best practices and tailored to its assets and the opportunities extending from Miami’s economic growth
YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...Levi Shapiro
Presentation by Yael Klionsky, YEDA, for the mHealth Israel community in September, 2023. Title: Challenges in Academic Technology Transfer. Examples-
Transplantation Immunology and Immunometabolism. Efranat Pharma was developing an anticancer immunotherapy treatment based on a natural plasma protein molecule. From target discovery to clinical validation. Clinical-stage drug discovery and development company utilizing a broadly applicable, predictive
computational discovery platforms to identify novel drug targets and new biological pathways and develop
therapeutics in the field of cancer immunotherapy. To allow SOCIETY to benefit from discoveries made at the academic institution. To enable SCIENTISTS to transfer their new technologies to the market. To create an additional source of INCOME for the INSTITUTE so that more independent research can be conducted. Three important elements that make an idea patentable:
1) The invention must be new: the same idea can’t have been
published before in any form; 2) There must be some inventive step of ‘non-obviousness’.
This can be hard to define and depends on the context; 3) The disclosure in a patent must be sufficient for a skilled
person to reproduce the invention with only routine effort; Technology Transfer Company - modus operandi; OUR PURPOSE- To provoke transformative scientific breakthroughs that will shape the future of humanity; SCIENTIFIC STAFF- 300 Principal investigators, >2,000 Research students and PhDs; 5 FACULTIES – BASIC SCIENCE, Biology, Physics, Biochemistry, Math/CS
Chemistry; Generated IP- 57% in Life Science & Biotech; Among the Highest
Income per Researcher
Worldwide; 1959 (First TTO outside the US); Today- More applications per PI than in most Ivy league universities; Copaxone- >$30B
ANNUAL SALES BASED ON Weizmann IP; 20 new licenses per year and 10 new companies per annum; www.yedarnd.com
HADASIT: Tech Transfer and More in Life ScienceLevi Shapiro
Overview of activities in Life Science of Hadasit, the technology transfer arm of Hadassah Hospital in Jerusalem. Includes details about Jerusalem Biodesign program; spinouts like Brainwatch; details about tech transfer (the Secret Engine Behind Israel’s Success); relationship and examples of TTOs enabling Israel's greatest success stories; contrasting of Adademia (Scientific driven research, Creation of new knowledge, Publication, Sharing of Material, Social responsibilities) and Industry (Applied research & specific objectives, Develop new products, Product development, Secrecy and patent protection, Organization responsibilities); Development gap between initial inventions and product development; the Art of translation (from academic research to medical companies); Tech transfer transforms cutting-edge research into marketable healthcare technologies; LICENSING TO EXISTING COMPANIES; SPINNING OFF STARTUPS; CO-DEVELOPMENT OF JOINT IP; Technology Transfer Offices from Academia/Research Hospitals – to Industry; Overview of Hadassah and Hadasit (TECHNOLOGY TRANSFER COMPANY AND INNOVATION ENGINE OF HADASSAH UNIVERSITY HOSPITALS); Examples of “HADASSAH MADE” PRODUCTS IN THE GLOBAL MARKET; RECENT TECH TRANSFER SUCCESS; Example- Lineage Exclusive Worldwide Collaboration with Genentech Opregen® RPE Cell Therapy for the Treatment of Ocular Disorders; HADASIT PILLARS-
NURTURING INTERNAL INNOVATION, Tech Transfer, EXTERNAL INNOVATION. External- SERVICES & COLLABORATIONS WITH COMPANIES, BIOHOUSE FOR STARTUPS, DIGITAL HEALTH ACCELERATOR); Internal Innovation- NURTURING INTERNAL INNOVATION, HADASSAH SEED FUND, JERUSALEM BIODESIGN PROGRAM; TYPES OF RELATIONS WITH EXTERNAL COMPANIES- CONSULTING, SAB, CLINICAL TRIALS, R&D SERVICES, DATA LICENCE, ALPHA/BETA SITE, PILOTS, DESIGN PARTNERSHIPS.
Presenting to Investors & the Media.pdfLevi Shapiro
Presenting to Investors and the Media, lecture by Drew Levinson, LifeSci Communications to mHealth Israel. Three sections: Making a good presentation, Handling
interviews with reporters and Answers that resonate. PRESENTING TO INVESTORS AND THE MEDIA- Compelling delivery, Commanding a room, • Lasting Impact. A good presentation includes Information, Motivation and Excitement. Never put them to sleep. Audience impact includes content, credibility and delivery. Decisions are made leading to potential partnerships, winning business, so much more than a deck, your business, your brand, you. How to captivate begins with storytelling and conversation. More than features- benefits, humanize, positive impact. Don't complicate your message with jargon. Feel the passion- contagious, vision, determination. Know your audience- who are they, what do they know about you, how much do they know, interests, concerns. Articulate your vision- see it, feel it, believe in it. Take them on your journey- compelling narrative, make it personal, why are you doing this, inspiration. Your team- experienced, knowledgeable, aligned, execute. Risks and challenges- recognize, address, plan to mitigate. Test drive your room. What does it look like? Where is the podium? Where will I be standing? Where will you be sitting? Feel comfortable. Three parts to attention. The beginning- attention, interest, what's in it for them, entusiasm, preview. The middle- core, insights, challenges, solutions, relatable. The ending- summary, reinforce, messages, benefits, call to action, keep the momentum going. How to answer questions. The Four R's: repeat, reinforce, refer, remember. Talking to reporters- necessity; Good interview can enhance reputation; Bad interview can tarnish reputation; Preparation is vital. Shapes public opinion: Elevates your brand; Establishes authority; Showcases your business; A bridge; Reputation; Trust; Visibility. Know the reporter. Audience; What have they written; Previous stories; Questions asked. Concise- clear, succinct, engaging. Make it relatable: Stories; Anecdotes; Experiences; Examples; Metaphors; Connect. Honesty and transparency. It is okay not to know every answer. You don’t have to answer every question. Control the narrative. What not to do when talking to reporters. Come up with another way to say no comment. What to wear- solid colors, blues and grays, nothing distracting. Expertise, passion, vision, lasting impression, connections. High stakes, high rewards. Preparation; Know your audience; Deliver with confidence; Enthusiasm; Authenticity. Begin the journey. Engage in dialogue; Build relationships; Inspire trust and confidence; Valued; Enlightened; Motivated and excited.
Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...Levi Shapiro
Presentation by Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgical Navigation Company and What's Next for XR. Covers the company founding across multiple milestones and key success factors.
Beyeonics CEO, Ron Schneider, Advances in Medical XRLevi Shapiro
Overview by Beyeonics CEO, Ron Schneider, about the company. Beyeonics One is the first ophthalmic exoscope with an augmented reality surgical headset. It is a high-definition, fully digital imaging platform enabling surgeons to see a magnified, three-dimensional (3D) image of the surgical field. The small footprint, the fast setup, automation, and zero turnover time between procedures all contribute to the efficiency operating rooms strive for. Over 3000 cases to date. Unconstrained Movement. Unconstrained workflow. Data connectivity. Designed for continuous innovation.
XRHealth is revolutionizing healthcare, bringing patient care into the Metaverse. Includes a description of the TeleHealth Platform. Lessons Learned – Building the clinical Metaverse. Last mile delivery
Building a product in the Metaverse is easy – getting people to use it is hard. Virtual Care can’t be based only on XR. HMDs bring friction – Charging, Guardian, Safety, Passwords etc. Expanding virtually in a brick & mortar payer environment. Once you cross the chasm – adherence/ satisfaction/retention goes ballistic. Patient Outcomes-
Patients report significant improvement in symptoms following treatment. Adherence - patients follow Home Exercise Plans as prescribed. 92.2% with XRHealth vs 50% with regular treatment. Patient satisfaction - 85 NPS vs 38 NPS in healthcare
93.3% patient retention -complete treatment cycle as prescribed. XRHealth Luna AI Reduces Hot Flashes and Improves Psychological Well-Being in Women with Breast and Ovarian Cancer: A Pilot Study. Virtual reality immersion compared to monitored anesthesia care for hand surgery: A randomized controlled trial. Lessons Learned – Autism Spectrum Disorder. The future of the Mediverse.
Digital Health in US Health Systems.pptxLevi Shapiro
April, 2023 presentation by Gil Bashe, Global Chair, Health Practice, FINN Partners. Insights and analytics, in collaboration with Galen Growth, tracking Digital Health collaboration, adoption, integration, and best practices across the leading US Health Systems. There is a section about focus areas for digital health in health systems and hospitals. The most active health systems are partnering more in diagnosis and have a higher share of digital tools for research. Comprehensive breakout of digital health activities at the Top 10 players: Mayo, Mount Sinai, Cleveland Clinic, Sloan Kettering, Massachusetts General, Northwell, Cedars Sinai, Brigham & Women's, InterMountain. Global breakout of health systems with digital health partnerships at scale. Geographical breakout of digital health partner headquarters (by region). Strong preference for B2B business model. 1/3 of digital health partnerships with Early Stage venture companies. Emphasis is on strong clinical evidence. Portfolio size allows greater diversity. Cluster distribution depends on therapeutic area. Digital health analytics breakout including alpha score, venture similarity score, venture valuation, team signal, partnership signal, evidence signal.
Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...Levi Shapiro
Syllabus for the Future of Digital Medicine course, 2023- Biology, Genetics, Technology and BioInformatics. Includes lectures from Noam Shomron, Michal Rosen-Zvi, Eyal Zimlichman, Gila Tolub, Dana Bar-On, Yesha Sivan, Vladi Dvoryis, Varda Shalev, Avi Schroeder, Christian Tidano, Eyal Toledano.
The secret way to sell pi coins effortlessly.DOT TECH
Well as we all know pi isn't launched yet. But you can still sell your pi coins effortlessly because some whales in China are interested in holding massive pi coins. And they are willing to pay good money for it. If you are interested in selling I will leave a contact for you. Just what'sapp this number below. I sold about 3000 pi coins to him and he paid me immediately.
+12349014282
Financial Assets: Debit vs Equity Securities.pptxWrito-Finance
financial assets represent claim for future benefit or cash. Financial assets are formed by establishing contracts between participants. These financial assets are used for collection of huge amounts of money for business purposes.
Two major Types: Debt Securities and Equity Securities.
Debt Securities are Also known as fixed-income securities or instruments. The type of assets is formed by establishing contracts between investor and issuer of the asset.
• The first type of Debit securities is BONDS. Bonds are issued by corporations and government (both local and national government).
• The second important type of Debit security is NOTES. Apart from similarities associated with notes and bonds, notes have shorter term maturity.
• The 3rd important type of Debit security is TRESURY BILLS. These securities have short-term ranging from three months, six months, and one year. Issuer of such securities are governments.
• Above discussed debit securities are mostly issued by governments and corporations. CERTIFICATE OF DEPOSITS CDs are issued by Banks and Financial Institutions. Risk factor associated with CDs gets reduced when issued by reputable institutions or Banks.
Following are the risk attached with debt securities: Credit risk, interest rate risk and currency risk
There are no fixed maturity dates in such securities, and asset’s value is determined by company’s performance. There are two major types of equity securities: common stock and preferred stock.
Common Stock: These are simple equity securities and bear no complexities which the preferred stock bears. Holders of such securities or instrument have the voting rights when it comes to select the company’s board of director or the business decisions to be made.
Preferred Stock: Preferred stocks are sometime referred to as hybrid securities, because it contains elements of both debit security and equity security. Preferred stock confers ownership rights to security holder that is why it is equity instrument
<a href="https://www.writofinance.com/equity-securities-features-types-risk/" >Equity securities </a> as a whole is used for capital funding for companies. Companies have multiple expenses to cover. Potential growth of company is required in competitive market. So, these securities are used for capital generation, and then uses it for company’s growth.
Concluding remarks
Both are employed in business. Businesses are often established through debit securities, then what is the need for equity securities. Companies have to cover multiple expenses and expansion of business. They can also use equity instruments for repayment of debits. So, there are multiple uses for securities. As an investor, you need tools for analysis. Investment decisions are made by carefully analyzing the market. For better analysis of the stock market, investors often employ financial analysis of companies.
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdfcoingabbar
Introducing BONKMILLON - The Most Bonkers Meme Coin Yet
Let's be real for a second – the world of meme coins can feel like a bit of a circus at times. Every other day, there's a new token promising to take you "to the moon" or offering some groundbreaking utility that'll change the game forever. But how many of them actually deliver on that hype?
Yes of course, you can easily start mining pi network coin today and sell to legit pi vendors in the United States.
Here the what'sapp contact of my personal vendor.
+12349014282
#pi network #pi coins #legit #passive income
#US
when will pi network coin be available on crypto exchange.DOT TECH
There is no set date for when Pi coins will enter the market.
However, the developers are working hard to get them released as soon as possible.
Once they are available, users will be able to exchange other cryptocurrencies for Pi coins on designated exchanges.
But for now the only way to sell your pi coins is through verified pi vendor.
Here is the what'sapp contact of my personal pi vendor
+12349014282
2. Elemental Economics - Mineral demand.pdfNeal Brewster
After this second you should be able to: Explain the main determinants of demand for any mineral product, and their relative importance; recognise and explain how demand for any product is likely to change with economic activity; recognise and explain the roles of technology and relative prices in influencing demand; be able to explain the differences between the rates of growth of demand for different products.
STREETONOMICS: Exploring the Uncharted Territories of Informal Markets throug...sameer shah
Delve into the world of STREETONOMICS, where a team of 7 enthusiasts embarks on a journey to understand unorganized markets. By engaging with a coffee street vendor and crafting questionnaires, this project uncovers valuable insights into consumer behavior and market dynamics in informal settings."
BYD SWOT Analysis and In-Depth Insights 2024.pptxmikemetalprod
Indepth analysis of the BYD 2024
BYD (Build Your Dreams) is a Chinese automaker and battery manufacturer that has snowballed over the past two decades to become a significant player in electric vehicles and global clean energy technology.
This SWOT analysis examines BYD's strengths, weaknesses, opportunities, and threats as it competes in the fast-changing automotive and energy storage industries.
Founded in 1995 and headquartered in Shenzhen, BYD started as a battery company before expanding into automobiles in the early 2000s.
Initially manufacturing gasoline-powered vehicles, BYD focused on plug-in hybrid and fully electric vehicles, leveraging its expertise in battery technology.
Today, BYD is the world’s largest electric vehicle manufacturer, delivering over 1.2 million electric cars globally. The company also produces electric buses, trucks, forklifts, and rail transit.
On the energy side, BYD is a major supplier of rechargeable batteries for cell phones, laptops, electric vehicles, and energy storage systems.
1. THE IVC-KPMG SURVEY
Summary of Israeli Venture Capital Investments – Q3 2013
Marianna Shapira, Research Manager, IVC
October 2013
2. IVC-KPMG Survey
Summary of Israeli Venture Capital Investments – Q3/2013
Table of Contents
Methodology ........................................................................................................ 3
About the Authors............................................................................................... 3
Summary of Israeli Venture Capital Investments – Q3/2013 ......................... 4
Chart 1: Distribution of Israeli Venture Capital Investments by Type of Investor
Q1/2011 – Q3/2013 ($m) ......................................................................................... 4
Israeli VC-Backed Transactions .................................................................................. 5
Chart 2: Israeli VC-Backed Deals Q1/2011 – Q3/2013 ($m) .................................. 5
Israeli VC Fund Investment Activity ........................................................................... 6
Chart 3: Distribution of First and Follow-on Israeli VC Fund Investments (%) ..... 6
Investment Rounds Excluding Israeli VC Fund Participation ..................................... 7
Chart 4: Israeli VC Funds vs. Other Investors (%) Q1-Q3/2012 vs. Q1-Q3/2013 .. 7
Capital Raised by Sector .................................................................................... 8
Chart 5: Capital Raised by Israeli Internet Companies ($m) ................................... 8
Chart 6: Share of Capital Raised by Israeli High-Tech Companies by Sector
Q1/2011 – Q3/2013 ................................................................................................. 9
Capital Raised by Stage .................................................................................... 11
Chart 7: Share of Capital Raised by Israeli High-Tech Companies by Stage
Q1/2011 – Q3/2013 ............................................................................................... 11
Legal Disclaimer and Copyright...................................................................... 13
-2-
IVC Research Center Ltd. 99 HaHashmonaim St., 2nd Floor, Tel Aviv 67133, Israel www.ivc-online.com
Tel. +972-73-212-2333 Fax. +972-73-212-2323 E-mail: info@ivc-online.com
3. IVC-KPMG Survey
Summary of Israeli Venture Capital Investments – Q3/2013
Methodology
This Survey reviews capital raised by Israeli high-tech companies from Israeli and
foreign venture capital funds as well as other investors, such as investment companies,
corporate investors, incubators and angels. The Survey is based on reports from 129
investors of which 34 were Israeli VC management companies and 95 were other entities.
The survey covers total investments in the Israeli venture capital sector, including both
VC-backed rounds – where at least one investor participating in the round is a VC fund –
as well as deals not backed by venture capital funds. For more on our methodology
please click here.
For additional information, please visit: www.ivc-online.com
Marianna Shapira, Research Manager, IVC +972-73-212-2339 marianna@ivc-online.com
***
About the Authors
IVC Research Center is
Israel’s leading research center providing business leaders with an
unmatched wealth of data on Israel's high-tech, venture capital and private equity
industries. IVC products and services are used regularly by high-tech companies, venture
capital funds, private investors, financial investors and institutions, as well as public
entities such as the Central Bureau of Statistics, the Bank of Israel and the Office of the
Chief Scientist at the Economy Ministry.
IVC owns and operates the IVC Online Database (www.ivc-online.com) containing over
10,000 Israeli high-tech companies, venture capital funds, investment companies, angels
and technology incubators, as well as news updates and lots more. Among IVC products
and publications are the IVC Quarterly Survey, which for over 15 years has been
analyzing capital raising trends by Israeli high-tech companies, as well as the most
comprehensive guide to Israeli high technology and venture capital – the IVC High-Tech
Yearbook. The 2014 edition will be published in April 2014.
KPMG Somekh Chaikin’s
technology professionals offer insights and experience
accumulated from a long history of work with technology and life science companies.
Through a global network of highly qualified professionals in Israel, the Americas,
Europe, the Middle East, Africa and Asia-Pacific, KPMG helps clients address the
opportunities and challenges driven by new business models such as cloud computing,
mobile services and others. KPMG is a global network of professional firms providing
Audit, Tax and Advisory services. KPMG operates in 146 countries and has 140,000
people working in member firms throughout the world.
-3-
IVC Research Center Ltd. 99 HaHashmonaim St., 2nd Floor, Tel Aviv 67133, Israel www.ivc-online.com
Tel. +972-73-212-2333 Fax. +972-73-212-2323 E-mail: info@ivc-online.com
4. IVC-KPMG Survey
Summary of Israeli Venture Capital Investments – Q3/2013
Summary of Israeli Venture Capital Investments – Q3/2013
In Q3/2013, 162 companies raised $660 million from local and foreign investors, the
highest quarterly amount since 2000. This is an increase of 34 percent from $493 million
raised by 143 companies in Q2/2013, and 35 percent from $488 million attracted by 143
companies in Q3/2012. (Chart 1)
Chart 1: Distribution of Israeli Venture Capital Investments by Type of Investor
Q1/2011 – Q3/2013 ($m)
Five companies attracted more than $20 million each, accounting for 25 percent of the
total amount raised in Q3/2013. Nine companies attracted between $10 million and $20
million each, accounting for 16 percent of the total quarterly amount. Fifteen companies
raised from $5 million to $10 million each and 70 companies attracted more than $1
million each.
The average company financing round in Q3/2013 was $4.07 million, compared to $3.45
million in Q2/2013 and $3.41 million in Q3/2012.
In the first three quarters of 2013, 474 Israeli high-tech companies raised $1.63 billion, a
12 percent increase from $1.45 billion attracted by 413 companies in Q1-Q3/2012, and 4
percent above $1.56 billion invested in 422 companies in Q1-Q3/2011.
The average company financing round was $3.43 million, while average financing rounds
in Q1-Q3/2012 and Q1-Q3/2011 were $3.51 million and $3.7 million, respectively.
-4-
IVC Research Center Ltd. 99 HaHashmonaim St., 2nd Floor, Tel Aviv 67133, Israel www.ivc-online.com
Tel. +972-73-212-2333 Fax. +972-73-212-2323 E-mail: info@ivc-online.com
5. IVC-KPMG Survey
Summary of Israeli Venture Capital Investments – Q3/2013
Israeli VC-Backed Transactions
One hundred and one VC-backed deals attracted $462 million or 70 percent of the total
amount raised in Q3/2013. This compares to 86 deals totaling $399 million (81 percent)
in Q2/2013 and 98 deals totaling $376 million (77 percent) in Q3/2012. Remaining
capital raising rounds were completed by other investors – foreign and Israeli – without
the participation of VC funds. (Chart 2)
Chart 2: Israeli VC-Backed Deals Q1/2011 – Q3/2013 ($m)
The average financing round of VC-backed deals was $4.57 million, compared with
$4.64 million in Q2/2013 and $3.84 million in Q3/2012.
In Q1-Q3/2013, 288 VC-backed deals attracted $1.23 billion or 75 percent of the total
invested, an increase of 21 percent from the $1.01 billion (70 percent) raised in 257 VCbacked deals in Q1-Q3/2012, but a three percent decrease from $1.27 million (81 percent)
invested in 297 transactions in Q1-Q3/2011.
The average financing round for VC-backed deals was $4.26 million in Q1-Q3/2013,
compared with $3.95 million and $4.27 million in the corresponding periods in 2012 and
2011, respectively.
-5-
IVC Research Center Ltd. 99 HaHashmonaim St., 2nd Floor, Tel Aviv 67133, Israel www.ivc-online.com
Tel. +972-73-212-2333 Fax. +972-73-212-2323 E-mail: info@ivc-online.com
6. IVC-KPMG Survey
Summary of Israeli Venture Capital Investments – Q3/2013
Israeli VC Fund Investment Activity
In Q3/2013, $151 million was invested by Israeli VC funds, accounting for just 23
percent of total investments – the lowest quarterly share in a decade. This compares with
$123 million (25 percent) invested in Q2/2013 and $130 million (27 percent) invested in
Q3/2012. Remaining investments came from foreign and other Israeli investors.
First investments in Q3/2013 were $52 million (34 percent of total investments), a 49
percent increase from the $35 million (28 percent) of Q2, but 9 percent below the $57
million (44 percent) of Q3/2012. Follow-on investments by Israeli VC funds accounted
for 66 percent. (Chart 3)
Chart 3: Distribution of First and Follow-on Israeli VC Fund Investments (%)
Q3/2013’s average first investment was $2.74 million, while the average follow-on
investment was $1.24 million.
In Q1-Q3/2013, Israeli VC fund investments accounted for $418 million or 26 percent of
the total amount invested. This compares with $388 million (27 percent) in Q1-Q3/2012
and $488 million (31 percent) in Q1-Q3/2011.
First investments in Q1-Q3/2013 accounted for $145 million or 35 percent of total
investments, compared with 34 percent and 26 percent in Q1-Q3/2012 and Q1-Q3/2011,
respectively. Follow-on investments by Israeli VC funds made up the remaining 65
percent.
-6-
IVC Research Center Ltd. 99 HaHashmonaim St., 2nd Floor, Tel Aviv 67133, Israel www.ivc-online.com
Tel. +972-73-212-2333 Fax. +972-73-212-2323 E-mail: info@ivc-online.com
7. IVC-KPMG Survey
Summary of Israeli Venture Capital Investments – Q3/2013
Investment Rounds Excluding Israeli VC Fund Participation
In Q3/2013, venture capital deals without Israeli VC participation attracted $317 million,
48 percent of total investments. This compares with $189 million (38 percent) raised
without involvement of Israeli VC funds in Q2/2013 and $176 million (36 percent) in
Q3/2012.
Eight corporate venture capital funds participated in 10 deals accounting for $135 million
in Q3/2013. Israeli VC funds took part in four of those deals.
In Q1-Q3/2013, Israeli venture capital deals without involvement of Israeli VC funds
amounted to $701 million, up 5 percent from $665 million in the year-earlier period, and
49 percent from $470 million in Q1-Q3/2011. (Chart 4)
Chart 4: Israeli VC Funds vs. Other Investors (%) Q1-Q3/2012 vs. Q1-Q3/2013
-7-
IVC Research Center Ltd. 99 HaHashmonaim St., 2nd Floor, Tel Aviv 67133, Israel www.ivc-online.com
Tel. +972-73-212-2333 Fax. +972-73-212-2323 E-mail: info@ivc-online.com
8. IVC-KPMG Survey
Summary of Israeli Venture Capital Investments – Q3/2013
Capital Raised by Sector
In Q3/2013, 47 Internet companies attracted $179 million (27 percent), the largest
quarterly amount for the sector since 2000. This is a 103 percent increase from $88
million (18 percent) raised by 33 companies in Q2/2013, and a 180 percent jump from the
$64 million (13 percent) raised by 33 companies in the year-earlier period. (Chart 5)
Chart 5: Capital Raised by Israeli Internet Companies ($m)
The life sciences sector followed with 37 companies attracting $128 million or 20 percent
of quarterly investments. This is a 6 percent increase from $121 million (25 percent)
raised by 33 companies in Q2/2013, but a 23 percent decline from $166 million (34
percent) raised by 34 companies in the year-earlier period. In both previous periods, the
life sciences sector led quarterly investments. Within the life sciences, the medical
devices subsector attracted $68 million or 53 percent of the amount raised by the entire
sector, followed by therapeutics with $57 million or 45 percent.
Thirty software companies raised $104 million or 16 percent of all quarterly investments,
as did seven semiconductor firms. In the previous quarter, 26 software companies
attracted $81 million (16 percent) while in Q3/2012, 26 companies raised $74 million (15
percent). Ten semiconductor companies raised $66 million (13 percent) in Q2/2013 and
nine raised $64 million (13 percent) in Q3/2012.
Twenty-four communications companies followed with $81 million (12 percent – lowest
share in two years), up 3 percent from $79 million (16 percent) attracted by 30 companies
in the previous quarter, but down 22 percent from $104 million (21 percent) raised by 19
companies in Q3/2012.
Eight cleantech companies raised $35 million or 5 percent of investments, compared with
$56 million or 11 percent raised by nine companies in the previous quarter and $25
million or 5 percent raised by 15 companies in Q3/2012. Within cleantech, the
agrotechnology subsector accounted for $29 million or 83 percent of the amount raised by
the entire sector.
-8-
IVC Research Center Ltd. 99 HaHashmonaim St., 2nd Floor, Tel Aviv 67133, Israel www.ivc-online.com
Tel. +972-73-212-2333 Fax. +972-73-212-2323 E-mail: info@ivc-online.com
9. IVC-KPMG Survey
Summary of Israeli Venture Capital Investments – Q3/2013
Nine miscellaneous sector companies raised $29 million or 4 percent of total capital
raised in Q3/2013, compared with two companies that raised only $2 million or one
percent in the previous quarter and seven companies that raised $12 million or 3 percent
in Q3/2012. (Chart 6)
Chart 6: Share of Capital Raised by Israeli High-Tech Companies by Sector
Q1/2011 – Q3/2013
In Q1-Q3/2013, 125 Internet companies led all investments with $371 million (23 percent
of the total), up 36 percent from the $271 million raised in Q1-Q3/2012 (19 percent) by
99 companies and 8 percent from the $345 million (22 percent) raised in Q1-Q3/2011 by
88 companies.
One hundred life sciences companies followed with $340 million or 21 percent, a 19
percent decrease from $418 million (29 percent) attracted by 104 companies in the yearearlier period, when the sector led all investments. Within the life sciences, the medical
devices subsector attracted $195 million or 57 percent of the amount raised by the entire
sector and 12 percent of capital raised by all sectors.
Ninety software companies attracted $321 million (20 percent of total capital raised),
compared with $221million (15 percent) invested in 65 software companies in Q1Q3/2012 and $278 million (18 percent) invested in 72 software companies in Q1Q3//2011.
The communications sector was next with 85 companies that raised $228 million (14
percent), compared with 64 companies that attracted $241 million (17 percent) in Q1Q3/2012.
Twenty-five semiconductor companies attracted $190 million (11 percent), an increase of
62 percent from $117 million (8 percent) raised by 23 companies in Q1-Q3/2012, and 28
percent up from $149 million (9 percent) invested in 43 companies in Q1-Q3/2011.
-9-
IVC Research Center Ltd. 99 HaHashmonaim St., 2nd Floor, Tel Aviv 67133, Israel www.ivc-online.com
Tel. +972-73-212-2333 Fax. +972-73-212-2323 E-mail: info@ivc-online.com
10. IVC-KPMG Survey
Summary of Israeli Venture Capital Investments – Q3/2013
Thirty-two cleantech companies followed with $127 million (8 percent), up 76 percent
from the $72 million (5 percent) raised by 35 companies in the year-earlier period and 8
percent above $118 million raised by 39 companies in Q1-Q3/2011. The agrotechnology
subsector attracted $58 million or 46 percent of capital raised by the sector in Q1Q3/2013.
Seventeen miscellaneous sector companies followed with $50 million (3 percent),
compared with 23 companies that attracted $110 million (7 percent) in Q1-Q3/2012.
-10-
IVC Research Center Ltd. 99 HaHashmonaim St., 2nd Floor, Tel Aviv 67133, Israel www.ivc-online.com
Tel. +972-73-212-2333 Fax. +972-73-212-2323 E-mail: info@ivc-online.com
11. IVC-KPMG Survey
Summary of Israeli Venture Capital Investments – Q3/2013
Capital Raised by Stage
High-tech companies in this survey were divided into four categories: seed, early stage
(R&D), mid-stage (annual revenues up to $10 million) and late stage (annual revenues
over $10 million). (Chart 7)
Twenty-five seed companies raised $17 million (3 percent) in Q3/2013, a decrease of 37
percent from $27 million (5 percent) raised by 32 companies in the previous quarter, and
60 percent below the $43 million (9 percent) attracted by 32 seed companies in Q3/2012.
Within seed investments, Internet companies attracted the largest share – 35 percent –
followed by software with 29 percent.
Fifty-five early stage companies attracted $149 million (23 percent), compared with
$149million (30 percent) raised by 52 companies in the previous quarter and with $189
million (39 percent) raised by 48 companies in Q3/2012. From among early stage
investments, life science companies attracted the largest share of capital – 40 percent –
followed by semiconductors with 18 percent.
In Q3/2013, 69 mid-stage companies led capital raising with $366 million or 55 percent,
the highest quarterly amount for mid-stage in a decade. This compares with $235 million
or 48 percent raised by 51 companies in Q2/2013 and $211 million (43 percent) raised by
54 companies in Q3/2012. Within mid-stage investments, Internet companies attracted the
largest share – 27 percent – followed by life sciences with 18 percent.
Thirteen late stage companies attracted $128 million (19 percent), compared to eight
companies that raised $82 million (17 percent) in Q2/2013 and nine companies that raised
$45 million (9 percent) in Q3/2012. Within late stage investments, Internet attracted the
largest share of capital – 39 percent – followed by semiconductors with 32 percent.
Chart 7: Share of Capital Raised by Israeli High-Tech Companies by Stage
Q1/2011 – Q3/2013
-11-
IVC Research Center Ltd. 99 HaHashmonaim St., 2nd Floor, Tel Aviv 67133, Israel www.ivc-online.com
Tel. +972-73-212-2333 Fax. +972-73-212-2323 E-mail: info@ivc-online.com
12. IVC-KPMG Survey
Summary of Israeli Venture Capital Investments – Q3/2013
In Q1-Q3/2013, 110 seed companies raised $75 million (5 percent of the total raised),
down 26 percent from $101 million (7 percent) attracted by 105 seed companies in Q1Q3/2012, but 7 percent up from the $70 million (5 percent) raised by 81 companies in
Q1-Q3/2011.
One hundred and forty-four early stage companies attracted $390 million (24 percent) in
Q1-Q3/2013, a 18 percent decrease from $473 million (33 percent) raised by 130
companies in the year-earlier period and a 6 percent decline from $414 million (26
percent) raised by 117 companies in Q1-Q3/2011.
One hundred and eighty-nine mid-stage companies led all investments with $897 million
(55 percent) in the nine-month period. The amount is up 48 percent from $606 million (42
percent) attracted by 148 companies in Q1-Q3/2012 and 29 percent above the $696
million (45 percent) raised by 181 companies in Q1-Q3/2011.
Thirty-one late stage companies attracted $265 million (16 percent), compared to 30 that
raised $270 million (18 percent) in Q1-Q3/2012 and 43 that raised $382 million (24
percent) in Q1-Q3/2011.
-12-
IVC Research Center Ltd. 99 HaHashmonaim St., 2nd Floor, Tel Aviv 67133, Israel www.ivc-online.com
Tel. +972-73-212-2333 Fax. +972-73-212-2323 E-mail: info@ivc-online.com